Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes

Clinical trial NCT06609356 · RECRUITING

Trial details

NCT number: NCT06609356
Sponsor: Vanderbilt University Medical Center
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus Glucokinase-Maturity Onset Diabetes of the Young (GCK-MODY)MODY2 Diabetes Healthy Volunteer

Start date: 2025-07-03
Primary completion: 2027-07-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.